Please login to the form below

Not currently logged in
Email:
Password:

INC Research expands infectious diseases team with appointment of Dr Frederick Young

He joins the CRO from ICON, where he served as vice president of strategic programmes

INC Research has appointed ICON's former vice president of strategic programmes Dr Frederick Young as vice president of infectious diseases.

The contract research organisation (CRO) says the addition of Dr Young will support its work in global vaccine development research as well as expanding its infectious diseases team.

"Antibiotics and other antimicrobials have played a critical role in the fight against infectious diseases, but further discovery and evaluation of new treatments is still needed," said Patricia Monteforte, executive vice president and general manager, general medicine, INC Research.

"We've become a leader in infectious diseases research by having a therapeutically-focused team with experience in all stages and disciplines associated with the development of anti-infectives. With the addition of Frederick, INC Research is positioned to expand this therapeutic unit even further with experienced resources to support and advance our customers' research and development."

Prior to his time with ICON, where he worked for nearly four years, Dr Young served at Novartis in a number of roles, including clinical research scientist, executive director, project leader and, most recently, global programme director.

25th April 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics